BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Apollo Hospitals Q2 Results FY24-25: Revenue at ₹5,589.3 Crore, PAT up 63% to ₹378.8 Crore

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Apollo Hospitals delivered strong Q2 FY25 results, with consolidated revenue rising by 15% YoY to ₹5,589.3 Crore and PAT growing by 63% YoY to ₹378.8 Crore. The group's healthcare services and digital health segments contributed significantly, demonstrating solid growth momentum.

Key Highlights/Quick Insights: (Consolidated)

  • Revenue: ₹5,589.3 Crore, a 15% YoY increase
  • PAT: ₹378.8 Crore, a 63% YoY growth
  • EBITDA: ₹815.5 Crore, reflecting a 30% increase YoY
  • Digital Health & Pharmacy Distribution Revenue: ₹2,282.2 Crore, up 17% YoY

APOLLO HOSPITALS ENTER. L

Trade

6953-206.50 (-2.88 %)

Updated - 25 April 2025
7243.00day high
DAY HIGH
6898.00day low
DAY LOW
329965
VOLUME (BSE)

Quarterly Performance - Apollo Hospitals Q2 Results FY24-25

Apollo Hospitals reported consolidated revenue of ₹5,589.3 Crore in Q2 FY25, marking a 15% increase from Q2 FY24. The PAT for the quarter rose to ₹378.8 Crore, reflecting a strong growth of 63% YoY. EBITDA for the quarter grew by 30% to ₹815.5 Crore, with EBITDA margins showing resilience amid expansion activities.

Segment Highlights:

Healthcare Services:

  • Revenue of ₹2,903.2 Crore, representing a 14% YoY growth.
  • PAT stood at ₹364.3 Crore, reflecting a 16% increase.

Apollo HealthCo:

  • Revenue grew 17% YoY to ₹2,282.2 Crore.
  • Reported PAT of ₹19 Crore, a turnaround from a loss in the previous year.

Sector Expectations for Apollo Hospitals' Q2 FY25 Results

The company's strong performance aligns with the healthcare sector's growth trends, driven by increased demand for specialized services and digital health integration. Apollo Hospitals’ strategic initiatives in expanding its digital healthcare and pharmacy distribution services reflect its commitment to meet market needs and exceed sector expectations.

Management Commentary

Apollo Hospitals' leadership highlighted the solid growth in revenue and profitability, underscoring the success of its digital health initiatives. The focus on expanding healthcare accessibility, investing in advanced medical technology, and leveraging digital health channels will drive future growth and enhance shareholder value.

Consolidated Financial Table:

Particulars

Q2 FY25

Q2 FY24

YoY Change

Revenue

₹5,589.3 Crore

₹4,846.9 Crore

15%

PAT

₹378.8 Crore

₹232.9 Crore

63%

EBITDA

₹815.5 Crore

₹627.5 Crore

30%

Digital Health & Pharmacy Revenue

₹2,282.2 Crore

₹1,945.4 Crore

17%

Check out Apollo Hospitals’ past performances in previous quarters and financial years.

Conclusion

Apollo Hospitals' Q2 FY25 performance underscores its strong growth trajectory, backed by strategic expansion in healthcare services and digital health. As it looks ahead, the group's focus on advanced medical innovations and scalable healthcare solutions positions it well for sustained growth in the evolving healthcare landscape.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9.5 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4400+ Cr MTF Book

icon-with-text